An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures

Léon Nshimyumukiza, Audrey Durand, Mathieu Gagnon, Xavier Douville, Suzanne N. Morin, Carmen Lindsay, Julie Duplantie, Christian Gagné, Sonia Jean, Yves Giguère, Sylvie Dodin, François Rousseau, Daniel ReinharzJournal of Bone and Mineral Research 2012 · DOI

TL;DR

This paper uses a sophisticated simulation model to compare the cost-effectiveness and cost-utility of various strategies for preventing osteoporosis-related fractures in women. The key takeaway is that for younger women (40-64), promoting physical activity is the most cost-effective and even cost-saving approach. For older women (65+), a bone mineral density (BMD)-based screening program combined with risk assessment and targeted treatment emerges as a strong contender, especially if a certain budget threshold is met.

What Problem Does This Paper Address?

Osteoporosis is a significant public health concern, leading to debilitating fractures, particularly in older women. While various prevention and screening strategies exist, there's a need to understand their economic implications – specifically, which approaches offer the best value for money in terms of preventing fractures and improving quality of life. This paper tackles the challenge of comparing a wide array of these strategies, from simple lifestyle advice to complex screening protocols, within the Canadian healthcare system's economic constraints. The authors aim to provide evidence-based recommendations for optimizing resource allocation in osteoporosis prevention.

Methods

The core of this research is a patient-level Markov decision model (SPLMM). This is a computational tool that simulates the health outcomes and costs for a large virtual population (500,000 women aged 40+) over time. The model tracks individuals through different health states (e.g., healthy, fractured, receiving treatment) and calculates the direct costs incurred by the public healthcare system, the number of fractures averted, and the quality-adjusted life-years (QALYs) gained.

They compared 16 different intervention options categorized into three main scenarios:

  1. Status quo: No specific national prevention program.
  2. Universal primary prevention: Programs promoting lifestyle changes like physical activity and calcium/vitamin D intake.
  3. Universal screening and treatment: Programs that identify women at risk using tools like BMD scans and risk assessment algorithms (e.g., CAROC) and then tailor interventions (pharmacological treatment or lifestyle advice) based on that risk.

The model incorporated detailed input parameters derived from peer-reviewed literature, prioritizing Canadian data. They also conducted sensitivity analyses to assess how variations in key parameters (like participation rates or treatment efficacy) might affect the results, and probabilistic sensitivity analyses to evaluate the uncertainty around the findings.

Datasets

The study did not introduce new datasets but relied on a comprehensive review of existing literature, guidelines, and government reports to populate its model. Baseline parameters were retrieved from studies originating from Quebec, other Canadian provinces, the United States, Europe, and Australia. Specific data sources included:

  • Peer-reviewed literature on osteoporosis risk factors, fracture incidence, and treatment effectiveness.
  • Canadian guidelines on osteoporosis diagnosis and management (e.g., CAROC tool).
  • Government databases for cost estimations (e.g., Quebec's SIFO and APR-DRG systems).
  • Published utility values for health states (e.g., Health Utilities Index III).

Key Insights and Ideas

  • Physical activity is a surprisingly powerful and cost-effective intervention: For younger women (40-64), simply promoting physical activity emerged as the most cost-effective and even cost-saving strategy, outperforming more complex screening and treatment programs. This highlights the significant impact of lifestyle on fracture prevention.
  • Age matters significantly in strategy selection: The optimal approach shifts dramatically with age. What's best for a 50-year-old is not necessarily best for a 70-year-old.
  • Screening becomes more valuable with age: For women 65 and older, BMD-based screening, coupled with risk assessment (like the CAROC tool) and targeted pharmacological treatment for high-risk individuals, becomes a highly competitive strategy, especially when considering a reasonable budget threshold.
  • QALYs and fracture reduction often align: The cost-utility (QALYs) and cost-effectiveness (fractures averted) results generally mirrored each other, suggesting that strategies that prevent fractures also tend to improve quality of life.
  • The "status quo" is not necessarily the cheapest: While some interventions are cost-saving, the baseline "status quo" (no specific national program) isn't always the most economical when considering the long-term costs of fractures.

Key Results

  • For women 40-64 years old:
    • The physical activity promotion program was the most cost-effective (CE) and cost-saving option, dominating all others.
  • Its incremental cost-effectiveness ratio (ICER) compared to the status quo was negative (meaning it saved money and averted fractures).
  • For women 65 years and older:
    • A BMD-based screening program using the CAROC tool, followed by targeted treatment and lifestyle promotion, was identified as the best next alternative.
  • Its ICER was approximately $60,000 CAD per fracture averted** and **$50,000 CAD per QALY gained when compared to the physical activity program.
  • Probabilistic sensitivity analyses showed a 63% probability of cost-effectiveness at a ceiling ratio of $50,000 CAD per fracture averted, and 75% probability at the same ratio per QALY gained.
  • Overall: The addition of new cohorts annually did not change the ranking of the most desirable options.

Limitations and Future Work

The authors acknowledge several limitations:

  • Limited fracture sites: The model only considered hip, clinical vertebral, and wrist fractures, excluding other sites like the proximal humerus or pelvis, which could alter cost-effectiveness.
  • Exclusion of non-clinical vertebral fractures: These were excluded due to the assumption that they often don't lead to medical seeking behavior or significant costs, though they might cause disutility.
  • Participation rate assumptions: The study used the participation rate from Quebec's breast cancer screening program as a proxy for osteoporosis interventions, acknowledging that actual participation might differ.
  • No modeling of combined intervention effects: The study did not model the synergistic effects of combined interventions (e.g., physical activity + vitamin D + calcium), instead using the highest individual effect.
  • Exclusion of indirect costs: The analysis focused solely on direct healthcare costs, omitting indirect costs like government investment in sports facilities or individual out-of-pocket expenses, which could significantly impact the cost-effectiveness of lifestyle interventions.
  • Generalizability: While the CAROC tool has high concordance with other risk assessment tools (like FRAX), the findings are specific to the Canadian context and may require confirmation in other healthcare systems.

Future work could explore the impact of indirect costs and investigate the combined effects of various preventive interventions.

Summary updated

Abstract

A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings.
BibTeX
@article{nshimyumukiza2012economic,
  author = {Léon Nshimyumukiza and Audrey Durand and Mathieu Gagnon and Xavier Douville and Suzanne N. Morin and Carmen Lindsay and Julie Duplantie and Christian Gagné and Sonia Jean and Yves Giguère and Sylvie Dodin and François Rousseau and Daniel Reinharz},
  title = {{An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures}},
  journal = {Journal of Bone and Mineral Research},
  year = {2012},
  doi = {10.1002/jbmr.1758},
}
Figure